Bicara Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic from Q3 2023 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Bicara Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2023 to Q3 2025.
  • Bicara Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 54.6M shares, a 401% increase year-over-year.
  • Bicara Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 16.8B shares, a 2797% increase from 2023.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Bicara Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 54.6M +43.7M +401% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 54.5M +53.6M +5982% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 54.5M +53.8M +8147% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 16.8B Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 10.9M +10.3M +1724% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 897K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 660K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q3 2023 598K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12

Bicara Therapeutics Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 16.8B +16.2B +2797% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 580M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.